ELV Elevance Health Inc.
HealthcareAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
12.14
PEG
—
P/B
1.98
P/S
0.43
EV/EBITDA
12.10
DCF Value
$1,134.11
FCF Yield
7.5%
Div Yield
1.7%
Margins & Returns
Gross Margin
23.2%
Operating Margin
3.8%
Net Margin
2.6%
ROE
12.0%
ROA
4.2%
ROIC
7.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $50.18B | $1.76B | $— |
| Q4 null | $49.75B | $547.0M | $— |
| FY null | $199.13B | $5.66B | $— |
| Q3 null | $50.71B | $1.19B | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$401.81
Target (Median)
$403.50
Target Range
$331.00 - $498.00
Trading Activity
Insider Trades
View AllRelated AI Research
Company Info
Sector
Healthcare
Industry
Medical - Healthcare Plans
Country
US
Exchange
—
Beta
0.67
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.